Chemoinformaics analysis of (2R,3R)-2,3-DIHYDROXYBUTANEDIOIC ACID
| Molecular Weight | 150.086 | nRot | 3 |
| Heavy Atom Molecular Weight | 144.038 | nRig | 16 |
| Exact Molecular Weight | 150.016 | nRing | 0 |
| Solubility: LogS | -3.921 | nHRing | 0 |
| Solubility: LogP | 2.742 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 15.4928 |
| nHD | 4 | BPOL | 7.75524 |
| QED | 0.548 |
| Synth | 2.426 |
| Natural Product Likeliness | 0.722 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.284 |
| Pgp-sub | 0.014 |
| HIA | 0.06 |
| CACO-2 | -4.834 |
| MDCK | 0.0000163 |
| BBB | 0.103 |
| PPB | 0.997995 |
| VDSS | 0.369 |
| FU | 0.0104929 |
| CYP1A2-inh | 0.593 |
| CYP1A2-sub | 0.758 |
| CYP2c19-inh | 0.287 |
| CYP2c19-sub | 0.12 |
| CYP2c9-inh | 0.661 |
| CYP2c9-sub | 0.906 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.895 |
| CYP3a4-inh | 0.674 |
| CYP3a4-sub | 0.517 |
| CL | 13.839 |
| T12 | 0.948 |
| hERG | 0.214 |
| Ames | 0.234 |
| ROA | 0.896 |
| SkinSen | 0.958 |
| Carcinogencity | 0.706 |
| EI | 0.792 |
| Respiratory | 0.951 |
| NR-Aromatase | 0.619 |
| Antiviral | No |
| Prediction | 0.943667 |